DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 064008
The generic ingredient in PENTACEF is ceftazidime. There are seventeen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.
Summary for 064008
Tradename: | PENTACEF |
Applicant: | Glaxosmithkline |
Ingredient: | ceftazidime |
Patents: | 0 |
Therapeutic Class: | Antibacterials |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 064008
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 6GM/VIAL | ||||
Approval Date: | Mar 31, 1992 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10GM/VIAL | ||||
Approval Date: | Mar 31, 1992 | TE: | RLD: | No |
Complete Access Available with Subscription